Healthy Skepticism Library item: 6595

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Lexchin J.
Re: the promotion of Ponstan (mefenamic acid)
1995 Aug;

Abstract:

In Pakistan the subsidiary of Parke-Davis is marketing Ponstan (mefenamic acid) as being superior to paracetamol (acetaminophen) for the treatment of fever in children. The scientific literature does not support this claim.

Keywords:
*analysis/Pakistan/developing countries/Ponstan/Parke-Davis/children/antipyretics/quality of information/safety & risk information/Medical Lobby for Appropriate Marketing/MaLAM/EVALUATION OF PROMOTION: DRUG SAFETY/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES